Orphenadrine Citrate Injection, Solution
Product Images NDC 25021-651

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 25021-651). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Orp00 0005 01

Chemical structure of orphenadrine citrate shown as two molecular diagrams: the orphenadrine molecule on the left and the citrate ion on the right, connected by a dot indicating a salt form.*

FDA Label Image

Orp00 0005 02

The label for Orphenadrine Citrate Injection, USP shows a 60 mg per 2 mL (30 mg per mL) single-dose vial for intravenous or intramuscular use. Manufactured by Sagent Pharmaceuticals in Schaumburg, IL. The label includes the NDC 25021-651-02 and barcodes for identification.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.